Source:http://linkedlifedata.com/resource/pubmed/id/10933658
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2000-10-19
|
pubmed:abstractText |
A retrospective study of 96 Campylobacter jejuni isolated from farm animals and the environment showed that most were less susceptible than the NCTC type strain to nalidixic acid (MICs 4-32 mg/L), ciprofloxacin (MICs 1-2 mg/L) and erythromycin (MICs 16-64 mg/L), but had similar susceptibility to tetracycline (MICs 4-8 mg/L) and kanamycin (MICs 4-8 mg/L). None had the high MICs of ciprofloxacin (>32 mg/L) or erythromycin (1024 mg/L) typically associated with clinical resistance in this species. Some farms used antimicrobial agents, but there was no obvious association between the use of agents and the susceptibility of the isolates.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0305-7453
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
303-6
|
pubmed:dateRevised |
2006-4-19
|
pubmed:meshHeading |
pubmed-meshheading:10933658-Animals,
pubmed-meshheading:10933658-Animals, Domestic,
pubmed-meshheading:10933658-Anti-Bacterial Agents,
pubmed-meshheading:10933658-Birds,
pubmed-meshheading:10933658-Campylobacter jejuni,
pubmed-meshheading:10933658-Cattle,
pubmed-meshheading:10933658-Feces,
pubmed-meshheading:10933658-Great Britain,
pubmed-meshheading:10933658-Humans,
pubmed-meshheading:10933658-Retrospective Studies,
pubmed-meshheading:10933658-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:10933658-Sewage,
pubmed-meshheading:10933658-Sheep,
pubmed-meshheading:10933658-Water Microbiology
|
pubmed:year |
2000
|
pubmed:articleTitle |
Activity of antibiotics used in human medicine for Campylobacter jejuni isolated from farm animals and their environment in Lancashire, UK.
|
pubmed:affiliation |
Antimicrobial Agents Research Group, Division of Immunity and Infection, The Medical School, University of Birmingham, Birmingham, UK. l.j.v.piddock@bham.ac.uk
|
pubmed:publicationType |
Journal Article
|